Sydney Lupkin

Smokeless Tobacco-FDA

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns Sydney Lupkin

5 things we found in the FDA’s hidden device database Sydney Lupkin

Donald trump Grand Rapids Rally

Consumers rejected drug plan that mirrors Trump administration proposal Sydney Lupkin

Overcoming Opioids Better Drugs

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale Sydney Lupkin

Execution Drugs-Pfizer

Pfizer settles kickback case related to copay assistance for $24M Sydney Lupkin

Opioid Death Risks

Drugmakers blamed for blocking generics have jacked up prices Sydney Lupkin

Opioid Death Risks

Patients overpay for prescriptions 23% of the time, analysis shows Sydney Lupkin

Drugmakers dramatically boosted lobbying spending in Trump’s first quarter Sydney Lupkin

Page: 1